Fiche d'information compilée à partir de PubMed
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 30 articles PubMed · modèle : gemma4:31b
Résumé
Contexte
Usages traditionnels
Composés actifs
Mécanisme d'action
Preuves cliniques
Leaf extracts and modified arginine preparations were studied for potential as a dietary supplement for prophylaxis and correction of metabolic syndrome in a rat model [PMID:34445028]
Ethanolic extract of V. corymbosum increased endurance exercise capacity and delayed muscle fatigue in mice [PMID:33170760]
Phytochemical compounds derived from blueberries exhibit antitumor properties and may serve as an alternative for the prevention of oral cancer [PMID:37375955]
In vivo and in vitro experimental results and clinical evidence demonstrate health-promoting effects, including anti-oxidant, anti-inflammatory, anti-obesity, anti-cancer, and neuroprotective activities [PMID:35344717]
Synthèse des preuves
Sources PubMed
- 1.PMID: 25416254 (2015) — Blueberry (Vaccinium corymbosum L.). · Methods in molecular biology (Clifton, N.J.)
- 2.PMID: 39166248 (2024) — Managing fruit rot diseases of Vaccinium corymbosum. · Frontiers in plant science
- 3.PMID: 34993320 (2022) — The complete chloroplast genome of highbush blueberry (Vaccinium corymbosum). · Mitochondrial DNA. Part B, Resources
- 4.PMID: 38254547 (2024) — Content of Bioactive Compounds in Highbush Blueberry Vaccinium corymbosum L. Leaves as a Potential Raw Material for Food Technology or Pharmaceutical Industry. · Foods (Basel, Switzerland)
- 5.PMID: 34445028 (2021) — Highbush Blueberry (Vaccinium corymbosum L.) Leaves Extract and Its Modified Arginine Preparation for the Management of Metabolic Syndrome-Chemical Analysis and Bioactivity in Rat Model.